Analyst Reco. Morphic Holding, Inc.

Equities

MORF

US61775R1059

Market Closed - Nasdaq Other stock markets 03:59:48 2024-06-04 pm EDT			5-day change	1st Jan Change
30.55 ^USD	-0.33%		-0.73%	+5.78%

Jun. 04	Crystal Amber's Portfolio Company Wins US Regulatory Nod for Diabetes Device Study Amendment	MT
May. 21	Morphic Demonstrates Novel Real-Time Visualization of Small Molecule A4ß7 Inhibition of Gut-Trafficking Cells	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Citigroup Starts Morphic Holding With Buy Rating, $46 Price Target	Dec. 08	MT
RBC Cuts Price Target on Morphic Holding to $76 From $80, Keeps Outperform, Speculative Risk	Nov. 06	MT
BMO Capital Lowers Price Target on Morphic to $52 From $106, Maintains Outperform Rating	23-09-28	MT
Stifel Cuts Morphic Holding's Price Target to $33 From $61, Hold Rating Maintained	23-09-25	MT
BTIG Research Downgrades Morphic to Neutral From Buy	23-09-25	MT
Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69	23-08-09	MT
Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target	23-07-21	MT
BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating	23-04-26	MT
RBC Raises Price Target on Morphic Holding to $80 From $75, Keeps Outperform, Speculative Risk	23-04-26	MT
Wells Fargo Adjusts Morphic Price Target to $80 From $67, Maintains Overweight Rating	23-04-25	MT
SVB Securities Raises Price Target on Morphic Holding to $56 From $45, Maintains Outperform Rating	23-03-08	MT
Wells Fargo Adjusts Price Target on Morphic Holding to $78 From $77, Maintains Overweight Rating	22-11-08	MT
RBC Raises Price Target on Morphic Holding to $75 From $70, Maintains Outperform, Speculative Risk Rating	22-11-03	MT
Analyst recommendations: Amazon, AstraZeneca, Glencore, Morphic, Phoenix Group...	22-09-07
Stifel Starts Morphic at Buy With $44 Price Target	22-09-07	MT
Wells Fargo Securities Adjusts Morphic Holding's Price Target to $77 From $79, Reiterates Overweight Rating	22-08-04	MT
RBC Cuts Price Target on Morphic to $70 From $76, Maintains Outperform Rating, Speculative Risk Qualifier	22-08-04	MT
Morphic Holding Shares Rise After SVB Securities Initiates Coverage at Outperform	22-07-20	MT
SVB Securities Initiates Morphic Holding at Outperform With $45 Price Target	22-07-20	MT
SVB Leerink Initiates Coverage on Morphic Holding With Outperform Rating, $45 Price Target	22-07-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Morphic Holding, Inc.

Equities

MORF

US61775R1059

Analyst Reco.

Filters